GEMMA Biotherapeutics

GEMMABio, a new therapeutics company, will serve as the research and innovation arm to speed the research of and global access to life-changing advanced therapies for those living with rare diseases. Alongside Franklin Biolabs, GEMMABio will advance gene therapy research and deliver therapeutics to patients around the world significantly faster

Gene therapy ,rare disease,quality assurance,gxp operations,regulatory affairs,clinical development,discovery research,translational research,vector research,biomedical research,orphan disease,genetic disease,genetic medicine,aav vectors,bioinformatics,capsid engineering,and genome editing

Gemma biotherapeutics operates in the Biotechnology research industry.

Gemma biotherapeutics's revenue is 11m - 100m

Gemma biotherapeutics has 11 - 50 employees.